|Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization|
|Yuan, Meng-Ke; Tao, Yong; Yu, Wen-Zhen; Kai, Wang; Jiang, Yan-Rong|
|WOS标题词||Science & Technology|
|类目[WOS]||Biochemistry & Molecular Biology ; Ophthalmology|
|研究领域[WOS]||Biochemistry & Molecular Biology ; Ophthalmology|
|关键词[WOS]||RETINAL VEIN OCCLUSION ; OCULAR ANGIOGENESIS ; TUMOR LYMPHANGIOGENESIS ; DIABETIC-RETINOPATHY ; IN-VIVO ; VEGF ; EXPRESSION ; GLAUCOMA ; INHIBITION ; MODEL|
Purpose: To explore the in vivo anti-angiogenesis effects resulting from lentivirus-mediated RNAi of vascular endothelial growth factor (VEGF) in monkeys with iris neovascularization (INV).
Methods: Five specific recombinant lentiviral vectors for RNA interference, targeting Macaca mulatta VEGFA, were designed and the one with best knock down efficacy (LV-GFP-VEGFi1) in H1299 cells and RF/6A cells was selected by real-time PCR for in vivo use. A laser-induced retinal vein occlusion model was established in one eye of seven cynomolgus monkeys. In monkeys number1, 3, and 5 (Group 1), the virus (1x10(8) particles) was intravitreally injected into the preretinal space of the animal′s eye immediately after laser coagulation; and in monkeys number 2, 4, and 6 (Group 2), the virus (1x10(8) particles) was injected at 10 days after laser coagulation. In monkey number 7, a blank control injection was performed. In monkeys number 1 and 2, virus without RNAi sequence was used; in monkeys number 3 and 4, virus with nonspecific RNAi sequence was used; and in monkeys 5 and 6, LV-GFP-VEGFi1 was used.
Results: In monkey number 5, at 23 days after laser treatment, no obvious INV was observed, while fluorescein angiography of the iris revealed high fluorescence at the margin of pupil and point posterior synechiae. At 50 days after laser treatment, only a slight ectropion uvea was found. However, in the other eyes, obvious INV or hyphema was observed. The densities of new iridic vessels all significantly varied: between monkey number 5 and number 3 (36.01 +/- 4.49/mm(2) versus 48.68 +/- 9.30/mm(2), p=0.025), between monkey number 3 and monkey number 7 (48.68 +/- 9.30/mm(2) versus 74.38 +/- 9.23/mm(2), p=0.002), and between monkey number 5 and number 7 (36.01 +/- 4.49/mm(2) versus 74.38 +/- 9.23/mm(2), p<0.001).
Conclusions: Lentivirus-mediated RNAi of VEGF may be a new strategy to treat iris neovascularization, while further studies are needed to investigate the long-term effect.
|项目编号||7062065 ; RDB2009-42 ; 30901639 ; 2009B04|
|资助机构||Beijing Natural Science Foundation ; People&prime ; s Hospital of Peking university ; National Natural Science Foundation of China ; Beijing Novel Program|
|作者单位||Peking Univ, Peoples Hosp, Dept Ophthalmol, Beijing 100044, Peoples R China|
|Yuan, Meng-Ke,Tao, Yong,Yu, Wen-Zhen,et al. Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization[J]. MOLECULAR VISION,2010,16(187-89):1743-1753.|
|APA||Yuan, Meng-Ke,Tao, Yong,Yu, Wen-Zhen,Kai, Wang,&Jiang, Yan-Rong.(2010).Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization.MOLECULAR VISION,16(187-89),1743-1753.|
|MLA||Yuan, Meng-Ke,et al."Lentivirus-mediated RNA interference of vascular endothelial growth factor in monkey eyes with iris neovascularization".MOLECULAR VISION 16.187-89(2010):1743-1753.|